Literature DB >> 4958410

The binding of antibiotics to serum proteins.

G N Rolinson, R Sutherland.   

Abstract

Mesh:

Substances:

Year:  1965        PMID: 4958410      PMCID: PMC1510609          DOI: 10.1111/j.1476-5381.1965.tb01788.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  15 in total

1.  ENHANCEMENT OF ANTIMICROBIAL ACTIVITY OF PENICILLINS AND OTHER ANTIBIOTICS IN HUMAN SERUM BY COMPETITIVE SERUM BINDING INHIBITORS.

Authors:  C M KUNIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  A COMPARISON OF FOUR PHENOXYPENICILLINS.

Authors:  J M BOND; M BARBER; J W LIGHTBOWN; P M WATERWORTH
Journal:  Br Med J       Date:  1963-10-19

3.  A new orally effective penicllinase-stable penicillin--BRL. 1621.

Authors:  E T KNUDSEN; D M BROWN; G N ROLINSON
Journal:  Lancet       Date:  1962-09-29       Impact factor: 79.321

4.  [The binding of penicillins on the proteins of the blood and tissues].

Authors:  W SCHOLTAN; J SCHMID
Journal:  Arzneimittelforschung       Date:  1962-08

5.  Studies on binding of tetracyclines by dog and human plasma.

Authors:  L A WOZNIAK
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

6.  Serum binding, distribution and excretion of four penicillin analogues following intravenous injection in man.

Authors:  C M KUNIN
Journal:  Proc Soc Exp Biol Med       Date:  1961-06

7.  Oxacillin: laboratory and clinical evaluation.

Authors:  W M KIRBY; L S ROSENFELD; J BRODIE
Journal:  JAMA       Date:  1962-09-01       Impact factor: 56.272

8.  THE BINDING OF SULFONAMIDE DRUGS BY PLASMA PROTEINS. A FACTOR IN DETERMINING THE DISTRIBUTION OF DRUGS IN THE BODY.

Authors:  B D Davis
Journal:  J Clin Invest       Date:  1943-09       Impact factor: 14.808

9.  Antibacterial activity of serum after oral doses of tetracycline, demethylchlortetracycline, and 6-methyleneoxytetracycline.

Authors:  J S REMINGTON; M FINLAND
Journal:  Clin Pharmacol Ther       Date:  1962 May-Jun       Impact factor: 6.875

10.  BINDING OF SULFONAMIDES BY PLASMA PROTEINS.

Authors:  B D Davis
Journal:  Science       Date:  1942-01-16       Impact factor: 47.728

View more
  54 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Antimicrobial activity of ceftriaxone compared with cefotaxime in the presence of serum albumin.

Authors:  S K Nath; G A Foster; L A Mandell; C Rotstein
Journal:  Can J Infect Dis       Date:  1995-01

3.  The prophylactic use of antibiotics in cell culture.

Authors:  I Kuhlmann
Journal:  Cytotechnology       Date:  1995-06       Impact factor: 2.058

4.  Serum binding of antibiotics.

Authors: 
Journal:  Br Med J       Date:  1966-04-30

5.  The binding of polyphenols (rutin and some of its o-beta-hydroxyethyl derivatives) to human serum proteins.

Authors:  G Bauer-Staeb; P Niebes
Journal:  Experientia       Date:  1976-03-15

6.  Pharmacokinetics of imipenem in patients undergoing major colon surgery.

Authors:  M Erttmann; R Krausse; U Ullmann
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

7.  Cloxacillin concentrations in serum, subcutaneous fat, and muscle in patients with chronic critical limb ischemia.

Authors:  T B Jonsson; T K Nilsson; L H Breimer; J Schneede; B Arfvidsson; L Norgren
Journal:  Eur J Clin Pharmacol       Date:  2014-05-27       Impact factor: 2.953

8.  Epicillin: in vitro laboratory studies.

Authors:  H Basch; R Erickson; H Gadebusch
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

9.  Interaction of albumin and fusidic acid.

Authors:  F Güttler; L Tybring; H Engberg-Pedersen
Journal:  Br J Pharmacol       Date:  1971-09       Impact factor: 8.739

10.  In vitro activity of novobiocin against multiresistant strains of Enterococcus faecium.

Authors:  P French; E Venuti; H S Fraimow
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.